EuroAPI Header EuroAPI Header

X

CAS 2346620-55-9 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 2346620-55-9
Also known as: ((3ar,4r,6r,6ar)-6-((e)-4-(hydroxyimino)-2-oxotetrahydropyrimidin-1(2h)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate
Molecular Formula
C16H25N3O7
Molecular Weight
371.39  g/mol
InChI Key
PTOXFRUJQSZZMV-OJAKKHQRSA-N

1 2D Structure

CAS 2346620-55-9

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(3aR,4R,6R,6aR)-4-[(4E)-4-hydroxyimino-2-oxo-1,3-diazinan-1-yl]-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl 2-methylpropanoate
2.1.2 InChI
InChI=1S/C16H25N3O7/c1-8(2)14(20)23-7-9-11-12(26-16(3,4)25-11)13(24-9)19-6-5-10(18-22)17-15(19)21/h8-9,11-13,22H,5-7H2,1-4H3,(H,17,18,21)/t9-,11-,12-,13-/m1/s1
2.1.3 InChI Key
PTOXFRUJQSZZMV-OJAKKHQRSA-N
2.1.4 Canonical SMILES
CC(C)C(=O)OCC1C2C(C(O1)N3CCC(=NO)NC3=O)OC(O2)(C)C
2.1.5 Isomeric SMILES
CC(C)C(=O)OC[C@@H]1[C@@H]2[C@H]([C@@H](O1)N3CC/C(=N\O)/NC3=O)OC(O2)(C)C
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. ((3ar,4r,6r,6ar)-6-((e)-4-(hydroxyimino)-2-oxotetrahydropyrimidin-1(2h)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl Isobutyrate

2.3 Create Date
2021-09-09
3 Chemical and Physical Properties
Molecular Weight 371.39 g/mol
Molecular Formula C16H25N3O7
XLogP30.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count5
Exact Mass371.16925015 g/mol
Monoisotopic Mass371.16925015 g/mol
Topological Polar Surface Area119 Ų
Heavy Atom Count26
Formal Charge0
Complexity607
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
3680-69-1
Tofacitinib Citrate
Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and ...
Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming to global API standards, along with professional R&D and marketing teams, Hengkang’s operations span major pharmaceutical markets such as China, Europe, the CIS region, Japan, and South Korea. Hengkang has established long-term and stable relationships with nearly 70 countries overseas and hundreds of domestic enterprises.
Flag China
Digital Content Digital Content
1062580-52-2
Tofacitinib Citrate
Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and ...
Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming to global API standards, along with professional R&D and marketing teams, Hengkang’s operations span major pharmaceutical markets such as China, Europe, the CIS region, Japan, and South Korea. Hengkang has established long-term and stable relationships with nearly 70 countries overseas and hundreds of domestic enterprises.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY